Marilène Bolduc

737 total citations
22 papers, 587 citations indexed

About

Marilène Bolduc is a scholar working on Epidemiology, Molecular Biology and Biotechnology. According to data from OpenAlex, Marilène Bolduc has authored 22 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in Marilène Bolduc's work include Influenza Virus Research Studies (7 papers), Transgenic Plants and Applications (7 papers) and vaccines and immunoinformatics approaches (6 papers). Marilène Bolduc is often cited by papers focused on Influenza Virus Research Studies (7 papers), Transgenic Plants and Applications (7 papers) and vaccines and immunoinformatics approaches (6 papers). Marilène Bolduc collaborates with scholars based in Canada, Mexico and United States. Marilène Bolduc's co-authors include Denis Leclerc, Nathalie Majeau, Pierre Savard, Christian Savard, Réjean Lapointe, Dominique L. Ouellet, Annie Guérin, Bernard Willems, Jérôme Alexandre Denis and Philippe A. Tessier and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Virology.

In The Last Decade

Marilène Bolduc

22 papers receiving 573 citations

Peers

Marilène Bolduc

BIOTE

EPIDE

ECOLO

Л. М. Цыбалова Russia

Tim D. Jones United Kingdom

Lesley McLain United Kingdom

Л. А. Степанова Russia

Andris Dišlers Latvia

Tineke Rutgers United States

Rosamund Chapman South Africa

Ina Baļķe Latvia

Lizhong Luo Canada

Natalie K. Connors Australia

Л. М. Цыбалова Russia

Marilène Bolduc

262 ×1.1

125 ×0.6

214 ×1.0

BIOTE

316 ×1.9

EPIDE

80 ×0.5

ECOLO

Citations per year, relative to Marilène Bolduc Marilène Bolduc (= 1×) peers Л. М. Цыбалова

Countries citing papers authored by Marilène Bolduc

Since Specialization

Citations

This map shows the geographic impact of Marilène Bolduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilène Bolduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilène Bolduc more than expected).

Fields of papers citing papers by Marilène Bolduc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilène Bolduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilène Bolduc. The network helps show where Marilène Bolduc may publish in the future.

Co-authorship network of co-authors of Marilène Bolduc

This figure shows the co-authorship network connecting the top 25 collaborators of Marilène Bolduc. A scholar is included among the top collaborators of Marilène Bolduc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilène Bolduc. Marilène Bolduc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bolduc, Marilène, Pierre Savard, Isabelle Dubuc, et al.. (2022). A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection. Nanomedicine Nanotechnology Biology and Medicine. 44. 102584–102584. 8 indexed citations

Langley, Joanne M., Élodie Pastural, Scott A. Halperin, et al.. (2020). A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age. Vaccines. 8(3). 393–393. 11 indexed citations

Bolduc, Marilène, et al.. (2019). Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform. Vaccines. 7(2). 49–49. 17 indexed citations

Bolduc, Marilène, et al.. (2018). The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses. Nanomedicine Nanotechnology Biology and Medicine. 14(8). 2563–2574. 19 indexed citations

Bolduc, Marilène, et al.. (2017). A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. Journal of Nanobiotechnology. 15(1). 54–54. 40 indexed citations

Herblot, Sabine, et al.. (2017). Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 2317–2327. 32 indexed citations

Russell, Alexis, et al.. (2016). Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine. Journal of Nanobiotechnology. 14(1). 43–43. 12 indexed citations

Bolduc, Marilène, et al.. (2015). Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. Vaccine. 33(51). 7245–7253. 33 indexed citations

Mathieu, Chantal, et al.. (2014). PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine. Journal of Nanobiotechnology. 12(1). 19–19. 17 indexed citations

10.

Savard, Christian, Marilène Bolduc, Annie Guérin, et al.. (2012). Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. Vaccine. 30(15). 2535–2542. 20 indexed citations

11.

Yang, Shaoqing, Tao Wang, Jen Bohon, et al.. (2012). Crystal Structure of the Coat Protein of the Flexible Filamentous Papaya Mosaic Virus. Journal of Molecular Biology. 422(2). 263–273. 46 indexed citations

12.

Savard, Christian, et al.. (2011). Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles. PLoS ONE. 6(6). e21522–e21522. 46 indexed citations

13.

Leclerc, Denis, et al.. (2011). PapMV nanoparticles open the breath of the immune response to the trivalent inactivated fl u vaccine. Journal of Antivirals & Antiretrovirals. 2(1). 2 indexed citations

14.

Bolduc, Marilène, Florent Dufour, Yves Langelier, et al.. (2010). Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes. Vaccine. 28(34). 5617–5626. 19 indexed citations

15.

Denis, Jérôme Alexandre, Nathalie Majeau, Christian Savard, et al.. (2007). Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization. Virology. 363(1). 59–68. 113 indexed citations

16.

Côté, Fabien, Nathalie Majeau, Marilène Bolduc, et al.. (2007). Nucleotide sequence and phylogenetic analysis of a new potexvirus: Malva Mosaic Virus. Infection Genetics and Evolution. 8(1). 83–93. 7 indexed citations

17.

Majeau, Nathalie, et al.. (2007). Effect of cAMP-dependent protein kinase A (PKA) on HCV nucleocapsid assembly and degradation. Biochemistry and Cell Biology. 85(1). 78–87. 9 indexed citations

18.

Tremblay, Marie‐Hélène, et al.. (2005). Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein. FEBS Journal. 273(1). 14–25. 44 indexed citations

19.

Majeau, Nathalie, et al.. (2005). Signal peptide peptidase promotes the formation of hepatitis C virus non-enveloped particles and is captured on the viral membrane during assembly. Journal of General Virology. 86(11). 3055–3064. 20 indexed citations

20.

Majeau, Nathalie, et al.. (2004). The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation. Journal of General Virology. 85(4). 971–981. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact